Grupo para el estudio de la salud cardiometabólica (GESCAMET)
GESCAMET
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (1)
2008
-
Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: Comparison with metformin
Hormone and Metabolic Research, Vol. 40, Núm. 12, pp. 892-895